Genus plc, the parent company of PIC (Pig Improvement Company), has announced that Colombia’s government issued a favorable regulatory determination for gene-edited pigs resistant to the porcine reproductive and respiratory syndrome virus. This means Colombia will treat the PRRS-resistant pigs the same as conventionally bred pigs.
It is important to note this determination will not automatically trigger sales of PRRS-resistant pigs in Colombia. PIC is working closely and transparently with all stakeholders in the animal protein value chain to establish a timeline for commercialization.
Read more at 20231006NHF-001_409&sfvc4enews=42&cl=article_2&utm_rid=CPG02000003679044&utm_campaign=79786&utm_medium=email&elq2=d33e6eb4450d4a55bf486d627cba5b61&sp_eh=6f157aca19193a2e454f1aced3afe1b4ea0550e56d12a86deed93a8d23f4c621″ target=”_blank”>National Hog Farmer 6 October 2023]